Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Depreciation and Depletion (2024 - 2025)

Historic Depreciation and Depletion for Cardiff Oncology (CRDF) over the last 2 years, with Q3 2025 value amounting to $89000.0.

  • Cardiff Oncology's Depreciation and Depletion fell 1188.12% to $89000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $376000.0, marking a year-over-year change of. This contributed to the annual value of $400000.0 for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Cardiff Oncology reported Depreciation and Depletion of $89000.0 as of Q3 2025, which was down 1188.12% from $94000.0 recorded in Q2 2025.
  • Cardiff Oncology's Depreciation and Depletion's 5-year high stood at $105000.0 during Q2 2024, with a 5-year trough of $89000.0 in Q3 2025.